Bibliographic details
Aragao F, Vera J, Vaz Pinto I. Cost-effectiveness of the third-agent class in treatment-naive human immunodeficiency virus-infected patients in Portugal. PLOS ONE 2012; 7(9):e44774
MeSH
Adult; Anti-HIV Agents /economics /pharmacology /therapeutic use; CD4 Lymphocyte Count /statistics & Cost-Benefit Analysis /statistics & Drug Resistance, Viral; Female; HIV Infections /drug therapy /immunology; HIV-1 /drug effects /physiology; Humans; Male; Middle Aged; Models, Statistical; Patient Compliance /statistics & Portugal; Probability; Reverse Transcriptase Inhibitors /economics /pharmacology /therapeutic use; Time Factors; Viral Load /drug effects; numerical data; numerical data; numerical data